Research on BRAF continues to evolve, focusing on understanding the mechanisms of resistance to BRAF inhibitors and finding new therapeutic strategies. Studies are also exploring the role of BRAF mutations in different cancers and their potential as biomarkers for early detection and personalized treatment. Advances in genomic technologies are aiding in the discovery of novel mutations and their implications.
